Genetic association of gemcitabine/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing-Reference-Cited by-同舟云学术

Genetic association of gemcitabine/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing

Published:2020-09 Issue: Volume:147 Page:106-114
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Svedberg Anna,Björn Niclas,Sigurgeirsson Benjamín,Pradhananga Sailendra,Brandén Eva,Koyi Hirsh,Lewensohn Rolf,De Petris Luigi,Apellániz-Ruiz María,Rodríguez-Antona Cristina,Lundeberg Joakim,Gréen Henrik

Funder

Swedish Cancer Society

Swedish Research Council, Linköping University, ALF

Funds of Radiumhemmet

Marcus Borgströms stiftelse

Spanish Ministry of Economy and Competitiveness

NBIS

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2015

2. Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer study Group;Sederholm;J. Clin. Oncol.,2005

3. Gemcitabine: a pharmacologic and clinical overview;Barton-Burke;Cancer Nurs.,1999

4. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II;Calvert;Cancer Chemother. Pharmacol.,1982

5. Phase III study by the Norwegian lung cancer study group: pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer;Gronberg;J. Clin. Oncol.,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway;Gynecologic Oncology;2024-11

2. Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review;Frontiers in Pharmacology;2024-08-21

3. Enhancer mutations modulate the severity of chemotherapy-induced myelosuppression;Life Science Alliance;2024-01-16

4. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer;Nature;2023-02-22

5. Evaluation of cfDNA as an early detection assay for dense tissue breast cancer;Scientific Reports;2022-05-19